miRNAs as Potential Treatment Targets and Treatment Options in Cancer

Published on Apr 1, 2018in Molecular Diagnosis & Therapy3.058
· DOI :10.1007/s40291-017-0314-8
Nina Petrovic8
Estimated H-index: 8
(University of Belgrade),
Sercan Ergun1
Estimated H-index: 1
(Ordu University)
Standard cancer therapies for solid malignancies, such as chemotherapy and radiotherapy, are not target specific against cancer cells and are often not fully efficacious. Chemotherapy and radiotherapy may cause side effects, and the need to develop additional strategies for cancer treatment is urgent. MicroRNAs (miRNAs) are small non-coding RNAs with heterogeneous functions and have been described in almost every known cancer model. Besides their basic tumor-suppressive and oncogenic functions, they also have the potential to modulate chemotherapy and radiotherapy and to be manipulated with chemical compounds to make them chemically suitable for efficient delivery to cancer cells. It has been suggested that the level of expression of specific miRNAs could increase treatment efficacy by determining the stage of chemotherapy/radiotherapy sensitivity. Application of miRNAs alone or in combination with standard therapeutic strategies may significantly improve the success of cancer treatments in the future.
  • References (73)
  • Citations (9)
📖 Papers frequently viewed together
2 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Tina Catela Ivkovic (Lund University)H-Index: 1
#2Gjendine Voss (Lund University)H-Index: 1
Last. Yvonne Ceder (Lund University)H-Index: 14
view all 4 authors...
During the last decades, basic and translational research has enabled great improvements in the clinical management of cancer. However, scarcity of complete remission and many drug-induced toxicities are still a major problem in the clinics. Recently, microRNAs (miRNAs) have emerged as promising therapeutic targets due to their involvement in cancer development and progression. Their extraordinary regulatory potential, which enables regulation of entire signalling networks within the cells, make...
37 CitationsSource
#1Nina Petrovic (University of Belgrade)H-Index: 8
#2Sercan Ergun (Ordu University)H-Index: 8
Last. Esma R. Isenovic (University of Belgrade)H-Index: 22
view all 3 authors...
MicroRNAs (miRNAs) are post-transcriptional regulators of gene expression, involved in the silencing of messenger RNA (mRNA) translation. The importance of miRNA signatures in disease screening, prognosis, and progression of different tumor types and subtypes is increasing. miRNA expression levels change depending on numerous factors. In this review, we are describing the circumstances under which miRNA levels can change, these are named ‘levels’ of heterogeneity of miRNAs. miRNAs can have oncog...
12 CitationsSource
#1Nina Petrovic (University of Belgrade)H-Index: 8
#2Ahmad Sami (University of Belgrade)H-Index: 1
Last. Snezana Jovanovic-Cupic (University of Belgrade)H-Index: 3
view all 7 authors...
Abstract Background Breast carcinomas (BC) belong to a heterogeneous group of malignant diseases. Correct categorization of BC based on molecular biomarkers has a very important role in deciding the proper course of therapy for each patient. It has been already shown that the decrease of TIMP metalloproteinase inhibitor 3 (TIMP-3) together with overexpression of microRNA-21 (miR-21) might be involved in the process of BC invasion. This is the first study that examined relationship among miR-21, ...
1 CitationsSource
#1Marta Geretto (UniGe: University of Genoa)H-Index: 3
#2Alessandra Pulliero (UniGe: University of Genoa)H-Index: 11
Last. Alberto Izzotti (UniGe: University of Genoa)H-Index: 46
view all 6 authors...
: Chemo-resistance, which is the main obstacle in cancer therapy, is caused by the onset of drug-resistant cells in the heterogeneous cell population in cancer tissues. MicroRNAs regulate gene expression at the post-transcriptional level, and they are involved in many different biological processes, including cell proliferation, differentiation, metabolism, stress response, and apoptosis. The aberrant expression of microRNAs plays a major pathogenic role from the early stages of the carcinogenes...
27 Citations
#1Melina Arnold (IARC: International Agency for Research on Cancer)H-Index: 17
#2Mónica S. Sierra (IARC: International Agency for Research on Cancer)H-Index: 9
Last. Freddie Ian BrayH-Index: 88
view all 6 authors...
Objective The global burden of colorectal cancer (CRC) is expected to increase by 60% to more than 2.2 million new cases and 1.1 million deaths by 2030. In this study, we aim to describe the recent CRC incidence and mortality patterns and trends linking the findings to the prospects of reducing the burden through cancer prevention and care. Design Estimates of sex-specific CRC incidence and mortality rates in 2012 were extracted from the GLOBOCAN database. Temporal patterns were assessed for 37 ...
687 CitationsSource
#1Ting Li (Anhui Medical University)H-Index: 22
#2Xiang-ling Meng (Anhui Medical University)H-Index: 1
Last. Wen-qi Yang (Anhui Medical University)H-Index: 1
view all 3 authors...
Background PVT1 was up-regulated in patients with gastric cancer (GC) and might be as a novel biomarker for predicting GC. However, the exact mechanism of PVT1 exerting functions in GC was still poorly understood. Emerging evidence suggests that long noncoding RNAs may act as endogenous microRNA (miRNA) sponges to bind to miRNAs and regulate their function.
26 CitationsSource
#1Dong Liu (HUST: Huazhong University of Science and Technology)H-Index: 6
#2Yawei Li (HUST: Huazhong University of Science and Technology)H-Index: 5
Last. Guosong Jiang (HUST: Huazhong University of Science and Technology)H-Index: 11
view all 11 authors...
Abstract Emerging evidences have indicated that long non-coding RNAs (LncRNAs) play vital roles in cancer development and progression. Previous studies have suggested that overexpression of SPRY4-IT1 predicates poor prognosis and promotes tumor progress in several cancers. However, the underlying mechanism of SPRY4-IT1 in bladder cancer remains unknown. In this study, we found that SPRY4-IT1 knockdown induced inhibition of cell proliferation, cell migration and invasion ability, and caused promo...
67 CitationsSource
#1Guang-jun HaoH-Index: 2
#2Hai‐jun HaoH-Index: 1
Last. Bing‐bing ZhangH-Index: 1
view all 7 authors...
Although microRNAs and EIF4G2 are both known to play pivotal roles in cancer progression, it remains unknown whether these pathways regulate chemosensitivity in a coordinated manner. Here, we show that miR-379 expression is significantly downregulated in chemoresistant non-small cell lung cancer (NSCLC) tissues and cells. Manipulation of miR-379 levels could alter the in vitro and in vivo cisplatin (CDDP) resistance in lung cancer (LCa) cells. Mechanistically, miR-379 potentiated LCa chemosensit...
19 CitationsSource
#1Lingyu Meng (Dalian Medical University)H-Index: 4
#2Cuicui Liu (Dalian Medical University)H-Index: 4
Last. Zuoren Yu (Ministry of Education)H-Index: 15
view all 17 authors...
MicroRNAs regulate a wide range of biological processes and being able to inhibit their function could allow the development of therapeutic options. Here the authors describe a ‘small RNA zipper’ that sequesters miRNAs by forming a chain of DNA:RNA duplexes.
13 CitationsSource
Radiotherapy (RT) is a widely used and effective non-surgical cancer treatment. However, the mechanism behind several major challenges to efficacy, such as tumor radioresistance, normal tissue toxicity, individual radiation hypersensitivity and promoted metastatic spread, are not fully understood. The involvement of microRNAs (miRNAs) in processes important for tissue radiation responses, including DNA damage repair, activation of signalling cascades or changes to the microenviroment, is being r...
5 CitationsSource
Cited By9
Abstract Tumor necrosis factor receptor superfamily 19 (TNFRSF19) is a transmembrane protein involved in tumorigenesis. RAB43 is a small molecule GTP-binding protein contributing to the occurrence and development of tumors. However, TNFRSF19/RAB43 dysregulation and their role in hepatocellular carcinoma cells are unknown. Herein, we found that TNFRSF19 and RAB43 were downregulated in hepatocellular carcinoma tissues. TNFRSF19/RAB43 overexpression suppressed, whereas TNFRSF19/RAB43 knockdown prom...
#1Kenneth K.W. To (CUHK: The Chinese University of Hong Kong)H-Index: 28
#2Winnie Fong (CUHK: The Chinese University of Hong Kong)H-Index: 1
Last. William C. S. ChoH-Index: 3
view all 6 authors...
ABSTRACTIntroduction: MicroRNAs (miRNAs) are small endogenous non-coding RNAs that repress the expression of their target genes by reducing mRNA stability and/or inhibiting translation. miRNAs are ...
2 CitationsSource
#1Abbas Jamshidi Avval (IAU: Islamic Azad University)
#2Ahmad Majd (IAU: Islamic Azad University)H-Index: 14
Last. Ghasem AhangariH-Index: 1
view all 6 authors...
BACKGROUND: Based on recent studies, new therapeutic strategies have been developed for cancer treatment using microRNAs (miRNAs). With this view, miRNAs manipulating techniques can be considered as novel therapeutic prospects for cancer treatment. In this study, we evaluated the expression of miR-4301 in human lung cancer cell lines and investigated its potential role in cell proliferation and tumor suppression on non-small cell lung cancer (NSCLC) cells. METHODS: We used quantitative real-time...
#1Jingjing HanH-Index: 2
#2Yaping LiuH-Index: 1
Last. Xuebin QuH-Index: 7
view all 9 authors...
MicroRNAs are powerful regulators of gene expression in physiological and pathological conditions. We previously showed that the dysregulation of miR-384 resulted in a T helper cell 17 (Th17) imbalance and contributed to the pathogenesis of experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. In this study, we evaluated the molecular mechanisms underlying the abnormal increase in miR-384. We did not detect typical CpG islands in the Mir384 promoter. Based on a bioinf...
#2Varinder JeetH-Index: 7
Last. Jyotsna BatraH-Index: 26
view all 5 authors...
BACKGROUND: Metabolic reprogramming is a hallmark of cancer. MicroRNAs (miRNAs) have been found to regulate cancer metabolism by regulating genes involved in metabolic pathways. Understanding this layer of complexity could lead to the development of novel therapeutic approaches. CONTENT: miRNAs are noncoding RNAs that have been implicated as master regulators of gene expression. Studies have revealed the role of miRNAs in the metabolic reprogramming of tumor cells, with several miRNAs both posit...
1 CitationsSource
Triple-negative (TNBC) is the most lethal subtype of breast cancer owing to high heterogeneity, aggressive nature, and lack of treatment options. Chemotherapy remains the standard of care for TNBC treatment, but unfortunately, patients frequently develop resistance. Accordingly, in recent years, tremendous effort has been made into elucidating the mechanisms of TNBC chemoresistance with the goal of identifying new molecular targets. It has become evident that the development of TNBC chemoresista...
2 CitationsSource
Although many diagnostic and therapeutic modalities for pancreatic cancer have been proposed, an urgent need for improved therapeutic strategies remains. Oligonucleotide therapeutics, such as those based on antisense RNAs, small interfering RNA (siRNA), microRNA (miRNA), aptamers, and decoys, are promising agents against pancreatic cancer, because they can identify a specific mRNA fragment of a given sequence or protein, and interfere with gene expression as molecular-targeted agents. Within the...
1 CitationsSource
#1Kioomars Saliminejad (Tehran University of Medical Sciences)H-Index: 1
Last. Seyed H. Ghaffari (Tehran University of Medical Sciences)H-Index: 14
view all 4 authors...
: MicroRNAs (miRNAs) are a class of small noncoding RNAs, which function in posttranscriptional regulation of gene expression. They are powerful regulators of various cellular activities including cell growth, differentiation, development, and apoptosis. They have been linked to many diseases, and currently miRNA-mediated clinical trial has shown promising results for treatment of cancer and viral infection. This review provides an overview and update on miRNAs biogenesis, regulation of miRNAs e...
19 CitationsSource
#1Nenad Janković (University of Kragujevac)H-Index: 5
#2Jovana Trifunović Ristovski (University of Novi Sad)
Last. Zorica M. Bugarčić (University of Kragujevac)H-Index: 10
view all 14 authors...
Abstract In order to investigate potential therapeutically agents, novel products of Biginelli reaction (4a-l) were synthesized and exposed to cytotoxic and caspase activities, angiogenesis, cell cycle distribution, gene and microRNA expression levels, lipophilicity assessment and docking study. Among the twelve novel compounds (4a-l) evaluated for the cytotoxic activity, five of them (4c, 4d, 4f, 4k and 4l) that showed excellent activity on the tested cell lines (HeLa, LS174 and A549) were sele...
#1Divya Ramchandani (Cornell University)H-Index: 4
#2Seung Koo Lee (Cornell University)H-Index: 18
Last. Vivek Mittal (Cornell University)H-Index: 42
view all 6 authors...
Triple-negative breast cancer (TNBC) patients exhibit the worst clinical outcome due to its aggressive clinical course, higher rate of recurrence, and a conspicuous lack of FDA approved targeted therapies. Here, we show that multilayered nanoparticles (NPs) carrying the metastasis suppressor microRNA miR-708 (miR708-NP) localize to orthotopic primary TNBC, and efficiently deliver the miR-708 cargo to reduce lung metastasis. Using a SOX2/OCT4 promoter reporter, we identified a population of miR-7...
2 CitationsSource